{"brief_title": "Study of Enfuvirtide in HIV-Positive Subjects", "brief_summary": "A total of 26 patients will be admitted to the clinic where they will be dosed with each injection device. There will be a 7-day washout between doses and a 7-10 day follow-up period.", "condition": "AIDS", "intervention_type": "Drug", "intervention_name": "Fuzeon", "criteria": "Inclusion Criteria: Exclusion Criteria:", "gender": "All", "minimum_age": "18 Years", "maximum_age": "64 Years", "healthy_volunteers": "No", "id": "NCT00086710.xml"}